All enrolled patients who acquired not less than one particular dose of zosuquidar or placebo during induction ended up monitored for the occurrence of adverse activities (439 people, 219 on zosuquidar and 210 on placebo). The commonest adverse situations had been connected to the duration of extended and significant myelosuppression as is anticipa… Read More